Cytocom, Inc. (CBLI) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Cytocom, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-18.16
Burn Risk
P/B Ratio
21.24
Weak
WeakModerateStrong
Earnings Yield
-5.61%
Yield Gap
Profitability Health
2020Return on Equity
-119.12%
Weak
WeakModerateStrong
Operating Margin
-983.70%
Weak
WeakModerateStrong
Net Profit Margin
-912.16%
Weak
WeakModerateStrong
Growth Indicators
2020Revenue Growth
-76.38%
Weak
WeakModerateStrong
Net Income Growth
9.39%
Moderate
WeakModerateStrong
EPS Growth
17.39%
Strong
WeakModerateStrong
Efficiency & Liquidity
2020Current Ratio
7.60
Strong
WeakModerateStrong
Quick Ratio
7.60
Strong
WeakModerateStrong
Asset Turnover
0.11x
Weak
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-5.55%
Weak
WeakModerateStrong
EV / Free Cash Flow
-17.20x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.82x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.870
Moderate
WeakModerateStrong
Return on Invested Capital
-55.57%
Weak
WeakModerateStrong
Cash Conversion Cycle
15.98 days
Moderate
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for CBLI.
View Financial Statements